![Regine Brokamp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Regine Brokamp
Chief Operating Officer at Selexis SA
Regine Brokamp active positions
Companies | Position | Start | End |
---|---|---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Chief Operating Officer | - | - |
Career history of Regine Brokamp
Former positions of Regine Brokamp
Companies | Position | Start | End |
---|---|---|---|
Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
Micromet AG
![]() Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - | - |
Statistics
International
Germany | 3 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Micromet AG
![]() Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Regine Brokamp
- Experience